Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - rivastigmine (as base) - patch, extended release - 18.00mg/10cm2 - rivastigmine (as base) 18.00mg/10cm2

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - rivastigmine (as base) - patch, extended release - 9mg/5cm2 - rivastigmine (as base) 9mg/5cm2

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - rivastigmine (as base) - patch, extended release - 27.000 mg - rivastigmine (as base) 27.000 mg

European Union - English - EMA (European Medicines Agency)

teva pharma b.v. - rivastigmine - dementia; alzheimer disease; parkinson disease - anticholinesterases - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.

European Union - English - EMA (European Medicines Agency)

3m health care limited - rivastigmine - alzheimer disease - psychoanaleptics, , anticholinesterases - symptomatic treatment of mild to moderately severe alzheimer's dementia.

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - rivastigmine base - transdermal patch - 4.6 mg/day - anticholinesterases

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - rivastigmine base - transdermal patch - 9.5 mg/day - anticholinesterases

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - rivastigmine base - transdermal patch - 4.6 mg/24 hours - anticholinesterases

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - rivastigmine base - transdermal patch - 9.5 mg/24 hours - anticholinesterases

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - rivastigmine hydrogen tartrate eqv rivastigmine - capsule - 1.5 mg - rivastigmine hydrogen tartrate eqv rivastigmine 1.5 mg